The Claim
Silencing choline kinase alpha (CHKA) in human retinal endothelial cells reduces proliferation, migration, and tube formation in vitro and decreases NAD+ levels, indicating that CHKA supports endothelial angiogenic functions through metabolic regulation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When choline kinase alpha (CHKA) is turned off in human retinal blood vessel cells, the cells show reduced ability to multiply, move, and form tube-like structures, and their NAD+ levels drop, demonstrating that CHKA is required for these angiogenic processes via metabolic regulation.
See the scientific wording
Silencing choline kinase alpha (CHKA) in human retinal endothelial cells reduces proliferation, migration, and tube formation in vitro, and decreases NAD+ levels, indicating CHKA supports endothelial angiogenic functions through metabolic regulation.
When choline kinase alpha is active, it keeps NAD+ levels high in eye blood vessel cells. High NAD+ turns on SIRT1, which removes a chemical tag from Notch, keeping it inactive. When Notch is off, the cells can grow, move, and form new blood vessels. If choline kinase alpha is turned off, NAD+ drops, SIRT1 stops working, Notch stays tagged and active, and the cells lose their ability to form new vessels.
What the research says
1 studyTurning off CHKA in eye blood vessel cells makes them less able to grow and form new vessels, and they also make less NAD+, a molecule they need to function. Giving back NAD+ helps fix some of the damage, proving CHKA is important for this process.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.